Zobrazeno 1 - 10
of 328
pro vyhledávání: '"E, McLoughlin"'
Publikováno v:
JMIR Cancer, Vol 10, p e56935 (2024)
Oral chemotherapy is commonly prescribed, and by using decision aids (DAs), clinicians can facilitate shared decision-making (SDM) to align treatment choices with patient goals and values. Although products exist commercially, little evidence informs
Externí odkaz:
https://doaj.org/article/659b8bf41b784c46845ad91f1a2e3ebb
Autor:
Ling Yu, Read Allen, Lin Jia, Ting Sun, Steven J. Isakoff, Marielle Scherrer-Crosbie, Allison M. Kehlmann, Hui Zheng, Amy Ly, Charlotte S. Walmsley, Katherine Hesler, Ava N. Varasteh, Christopher J. Pinto, Daniel E. McLoughlin, Wenjin Wu, Xinhui Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTrastuzumab is a targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, trastuzumab-induced cardiotoxicity (TIC) has been reported when trastuzumab is administered to patients as a single agent
Externí odkaz:
https://doaj.org/article/3d195d2bb1e644cabb2a0e090b1d001e
Autor:
Kirsten E. McLoughlin, Carolina N. Correia, John A. Browne, David A. Magee, Nicolas C. Nalpas, Kevin Rue-Albrecht, Adam O. Whelan, Bernardo Villarreal-Ramos, H. Martin Vordermeier, Eamonn Gormley, Stephen V. Gordon, David E. MacHugh
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Bovine tuberculosis, caused by infection with members of the Mycobacterium tuberculosis complex, particularly Mycobacterium bovis, is a major endemic disease affecting cattle populations worldwide, despite the implementation of stringent surveillance
Externí odkaz:
https://doaj.org/article/0a59da780d9844058e5ac7e541456e2c
Autor:
E. Sethe Burgie, Adam N. Bussell, Shu-Hui Lye, Tong Wang, Weiming Hu, Katrice E. McLoughlin, Erin L. Weber, Huilin Li, Richard D. Vierstra
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract Phytochromes (Phys) encompass a diverse collection of bilin-containing photoreceptors that help plants and microorganisms perceive light through photointerconversion between red light (Pr) and far-red light (Pfr)-absorbing states. In additio
Externí odkaz:
https://doaj.org/article/ff2574b5051f4fb99b8012360d76b029
Autor:
Nabeel Bardeesy, Cyril H. Benes, Lipika Goyal, Dejan Juric, Andrew X. Zhu, John D. Gordan, James R. Stone, Charlotte S. Walmsley, Daniel E. McLoughlin, Christopher J. Pinto, Islam Baiev, Vikram Deshpande, Cristina R. Ferrone, Xunqin Yin, Meng-Ju Wu, Regina Egan, Joshua Merritt, Ramzi Adil, Patricia Greninger, Phuong Vu, Lei Shi, Yuanli Zhen, Qibiao Wu
Supplementary Table from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931e04b614aba9b77872a721a0f534da
https://doi.org/10.1158/2159-8290.22540895
https://doi.org/10.1158/2159-8290.22540895
Autor:
Nabeel Bardeesy, Cyril H. Benes, Lipika Goyal, Dejan Juric, Andrew X. Zhu, John D. Gordan, James R. Stone, Charlotte S. Walmsley, Daniel E. McLoughlin, Christopher J. Pinto, Islam Baiev, Vikram Deshpande, Cristina R. Ferrone, Xunqin Yin, Meng-Ju Wu, Regina Egan, Joshua Merritt, Ramzi Adil, Patricia Greninger, Phuong Vu, Lei Shi, Yuanli Zhen, Qibiao Wu
Supplementary Figure from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422abc098d7c3a0f2950cc928525d9be
https://doi.org/10.1158/2159-8290.22540901
https://doi.org/10.1158/2159-8290.22540901
Autor:
Nabeel Bardeesy, Cyril H. Benes, Lipika Goyal, Dejan Juric, Andrew X. Zhu, John D. Gordan, James R. Stone, Charlotte S. Walmsley, Daniel E. McLoughlin, Christopher J. Pinto, Islam Baiev, Vikram Deshpande, Cristina R. Ferrone, Xunqin Yin, Meng-Ju Wu, Regina Egan, Joshua Merritt, Ramzi Adil, Patricia Greninger, Phuong Vu, Lei Shi, Yuanli Zhen, Qibiao Wu
FGFR inhibitors are approved for the treatment of advanced cholangiocarcinoma harboring FGFR2 fusions. However, the response rate is moderate, and resistance emerges rapidly due to acquired secondary FGFR2 mutations or due to other less-defined mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd84f4a0eca53b00c987cfcb283dbf4
https://doi.org/10.1158/2159-8290.c.6549500.v1
https://doi.org/10.1158/2159-8290.c.6549500.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qibiao Wu, Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Ramzi Adil, Joshua Merritt, Regina Egan, Meng-Ju Wu, Xunqin Yin, Cristina R. Ferrone, Vikram Deshpande, Islam Baiev, Christopher J. Pinto, Daniel E. McLoughlin, Charlotte S. Walmsley, James R. Stone, John D. Gordan, Andrew X. Zhu, Dejan Juric, Lipika Goyal, Cyril H. Benes, Nabeel Bardeesy
Publikováno v:
Cancer discovery, vol 12, iss 5
Cancer Discov
Cancer Discov
FGFR inhibitors are approved for the treatment of advanced cholangiocarcinoma harboring FGFR2 fusions. However, the response rate is moderate, and resistance emerges rapidly due to acquired secondary FGFR2 mutations or due to other less-defined mecha
Autor:
Carolina N. Correia, Kirsten E. McLoughlin, Nicolas C. Nalpas, David A. Magee, John A. Browne, Kevin Rue-Albrecht, Stephen V. Gordon, David E. MacHugh
Publikováno v:
Frontiers in Genetics, Vol 9 (2018)
RNA-seq has emerged as an important technology for measuring gene expression in peripheral blood samples collected from humans and other vertebrate species. In particular, transcriptomics analyses of whole blood can be used to study immunobiology and
Externí odkaz:
https://doaj.org/article/8c813cd258e24dab9280462d492b8c32